Sino Biopharmaceutical Limited
SBMFF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $89,474 | $59,378 | $51,730 | $56,873 |
| - Cash | $19,823 | $19,823 | $9,570 | $9,570 |
| + Debt | $11,956 | $11,956 | $9,784 | $9,784 |
| Enterprise Value | $81,606 | $51,511 | $51,944 | $57,087 |
| Revenue | $8,787 | $8,787 | $6,496 | $6,496 |
| % Growth | 0% | 35.3% | 0% | – |
| Gross Profit | $7,247 | $7,247 | $5,250 | $5,250 |
| % Margin | 82.5% | 82.5% | 80.8% | 80.8% |
| EBITDA | $1,969 | $1,969 | $1,084 | $1,090 |
| % Margin | 22.4% | 22.4% | 16.7% | 16.8% |
| Net Income | $1,694 | $1,694 | $241 | $241 |
| % Margin | 19.3% | 19.3% | 3.7% | 3.7% |
| EPS Diluted | 0.094 | 0.094 | 0.014 | 0.014 |
| % Growth | 0% | 571.4% | 0% | – |
| Operating Cash Flow | $1,580 | $1,580 | $0 | $0 |
| Capital Expenditures | -$135 | -$135 | $0 | $0 |
| Free Cash Flow | $1,445 | $1,445 | $0 | $0 |